Glatiramer Acetate - Neurology

Relevant Publications

Effect of autoimmune comorbidities on multiple sclerosis course: An observational multicenter study.

Issue Release: 2025

Patterns of disease-modifying therapy utilization before, during, and after pregnancy and postpartum relapses in women with multiple sclerosis.

Issue Release: 2024

TAURUS-MS II: real-world use of teriflunomide in Germany and changes in treatment patterns over time.

Issue Release: 2024

Utilization of peginterferon-β-1a in the real-world practice for relapsing-remitting multiple sclerosis.

Issue Release: 2024

Hypogammaglobulinaemia during rituximab treatment in multiple sclerosis: A Swedish cohort study.

Issue Release: 2024

The coincidence of multiple sclerosis and primary vasculitis; from the bench of pathology to the bedside of treatment: a systematic review of case reports.

Issue Release: 2024

Immunomodulators and immunosuppressants for progressive multiple sclerosis: a network meta-analysis.

Issue Release: 2024

A 2-stage model of heterogenous treatment effects for brain atrophy in multiple sclerosis utilizing the MS PATHS research network.

Issue Release: 2024

Impact of race and socioeconomic deprivation on clinical outcomes and healthcare utilization in pediatric multiple sclerosis.

Issue Release: 2024

Neutrophil-to-Lymphocyte Ratio, ESR, and CRP Have No Roles as Markers for Disease Severity and Prognosis in Patients with RRMS.

Issue Release: 2024

Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapies.

Issue Release: 2024

Simultaneous onset of Crohn\'s disease and Psoriasis in a Multiple Sclerosis patient treated with Teriflunomide: A novel case report highlighting potential autoimmune interactions.

Issue Release: 2024

Concurrent glioma and multiple sclerosis: A systematic review of case reports.

Issue Release: 2024

Prospective study validating a multidimensional treatment decision score predicting the 24-month outcome in untreated patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis, the ProVal-MS study.

Issue Release: 2024

Pregnancy and fetal outcomes following paternal exposure to glatiramer acetate.

Issue Release: 2024

Therapeutic lag: Is treatment effect delayed in progressive MS?

Issue Release: 2024

Use of multiple sclerosis disease-modifying therapies during pregnancy in France: Nationwide study between 2010 and 2021.

Issue Release: 2024

Treatment with glatiramer acetate in APPswe/PS1dE9 mice at an early stage of Alzheimer\'s disease prior to amyloid-beta deposition delays the disease\'s pathological development and ameliorates cognitive decline.

Issue Release: 2024

Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis.

Issue Release: 2024

Adverse Events Associated With Disease-Modifying Drugs for Multiple Sclerosis.

Issue Release: 2024

What is the Genetic Basis of Neurological Disorders?

Can Technology Aid in Improving Sleep Hygiene?

How Can Lifestyle Changes Help?

What is the Procedure for Testing Oligoclonal Bands?

How is PPMS Diagnosed?

Can the Mediterranean Diet Reduce the Risk of Neurodegenerative Diseases?

Why is Monitoring Progress Important in Neurocare?

What is Multiple Sclerosis?

What Role Does Psychiatry Play in Neurocare?

What Types of Genetic Mutations are Common in Neurology?

Glatiramer Acetate - Neurology

Relevant Publications

Partnered Content Networks

Relevant Topics